We are live on
!
Find out more
DCOY
Decoy Therapeutics
DCOY
DCOY
19 hedge funds and large institutions have $859K invested in Decoy Therapeutics in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
27% more funds holding
Funds holding: 15 → 19 (+4)
0% less ownership
Funds ownership: 0% → 0% (-0%)
41% less capital invested
Capital invested by funds: $1.45M → $859K (-$591K)
Holders
19
Holders Change
+4
Holders Change %
+26.67%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$112K |
| 2 |
Millennium Management
New York
|
+$60.4K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$43.1K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$17.3K |
| 5 |
EFL
ERn Financial LLC
Middleton,
Wisconsin
|
+$8.63K |
Top Sellers
| 1 |
KC
Kepos Capital
New York
|
-$218K |
| 2 |
BlackRock
New York
|
-$25.9K |
| 3 |
Two Sigma Advisers
New York
|
-$8.63K |
| 4 |
XSC
X-Square Capital
Guaynabo,
Puerto Rico
|
-$8.63K |
| 5 |
SRC
Shufro Rose & Co
New York
|
-$7K |
